Source access required
CVR360 has not loaded official Danish source data for this company yet. No AI or financial conclusion is generated without source-backed facts.
GH
GlycoPharma Holding ApS
aktivCVR 39691558AnpartsselskabRørhatten 4, 5220 Odense SØIkke-finansielle holdingselskaber
- Latest accounts
- 2025
- Statement scope
- Standalone
- Verified
- 05 Nov 2026
- Sources
- 5
What changed?
Source-backed changes, not an assessment.
1 source
Key figures
Latest period: 2025
Revenue
Data quality concern—
Data quality concern
Operating profit
Data quality concern—
Data quality concern
Net result
DKK -12.4k
Latest period
Source details
Source: dk-regnskabsdata-live-39691558-1793904870986
Document: dk-regnskabsdata-39691558-AZtEjnNN7yUF1StKdxXK-1
XBRL: fsa:ProfitLoss
Period: 01 Jul 2024 - 30 Jun 2025
Technical details
Context: D0
Unit: U-iso4217-DKK
Equity
DKK 684.1k
Equity ratio: 85.2%
Source details
Source: dk-regnskabsdata-live-39691558-1793904870986
Document: dk-regnskabsdata-39691558-AZtEjnNN7yUF1StKdxXK-1
XBRL: fsa:Equity
Period: 01 Jul 2024 - 30 Jun 2025
Technical details
Context: I0
Unit: U-iso4217-DKK
Development
Reported values. Missing periods appear as gaps.
RevenueNet result
Tabular view of development
| Year | Revenue | Net result |
|---|---|---|
| 2022 | — | DKK -7.3k |
| 2023 | — | DKK -13.6k |
| 2024 | — | DKK -15.4k |
| 2025 | — | DKK -12.4k |